Sex and Gender Womens Health Collaborative
  • HOME
  • Sex Matters
    • Historical Perspective
    • Research Policies
    • New Betting Sites Uk 2025
    • Non Gamstop Casinos Uk
    • Online Casinos
    • Non Gamstop Casinos
  • Resources
    • SGBM Practitioner Registry
    • Curriculum/Training
    • Teaching Tools
    • Presentations
    • Reports/Guidelines
    • Journal Articles
    • Newsletters
    • Recommended Links
  • Professional Education
    • SGBM Practitioner Registry
    • Case Studies
    • Online Courses
    • Medical Meetings
    • Recommended Books
    • Webinars
  • Blog
  • Participate
    • Founding Partners
    • Collaborators
    • Women’s Health Affiliations
    • Support
  • About
    • Vision and Mission
    • Bylaws
    • Who We Are
    • Board of Directors
    • Programs & Projects
    • Sex & Gender News
    • Peer Review Policy
    • Disclaimer
  • Contact Us
  • Home
  • Resources
  • Journal Articles
  • Estrogen May Protect Heart by Inhibiting Aldosterone Synthesis

Resources

  • SGBM Practitioner Registry
  • Curriculum/Training
  • Teaching Tools
  • Presentations
  • Reports/Guidelines
  • Journal Articles
  • Newsletters
  • Recommended Links

Tags

Autoimmune brain Cancer Cardiology Cardiovascular disease clinical care clinical research Cognition cognitive function CVD Depression diabetes diet Emergency Medicine Endocrinology FDA Genetics health care heart disease hypertension inflammatory diseases IOM medical devices medical education medication Mental Health Musculoskeletal Neurology NIH Nutrition Obesity Oncology Osteoporosis pain Pharmacology psychiatry Psychology psychosocial research research reporting Sleep stroke SWHR Women's Health Women's Health

Estrogen May Protect Heart by Inhibiting Aldosterone Synthesis

December 4, 2014 / SGWHC Editorial Staff / Journal Articles
0
Doctor_takes_blood_pressure

GPER-1 and Estrogen Receptor-β Ligands Modulate Aldosterone Synthesis

 
Authors: Brasilina Caroccia, Teresa M. Seccia, Abril Gonzalez Campos, Francesca Gioco, Maniselvan Kuppusamy, Giulio Ceolotto, Eugenia Guerzoni, Francesca Simonato, Sara Mareso, Livia Lenzini, Ambrogio Fassina, and Gian Paolo Rossi
 

Abstract

Fertile women have lower blood pressure and cardiovascular risk than age-matched men, which suggests that estrogens exert cardiovascular protective effects. However, whether 17 β-estradiol (E2) blunts aldosterone secretion, and thereby affects the gender dimorphism of blood pressure, is unknown. We therefore sought for the estrogen receptor (ER) subtypes in human adrenocortical tissues ex vivo by performing gene and protein expression studies. We also investigated the effect of E2 on aldosterone synthesis and the involved receptors through in vitro functional experiments in the adrenocortical cells HAC15. We found that in the human adrenal cortex and aldosterone-producing adenoma cells, the most expressed ERs were the ERβ and the G protein-coupled receptor-1 (GPER-1), respectively. After selective ERβ blockade, E2 (10 nmol/L) markedly increased both the expression of aldosterone synthase and the production of aldosterone (+5- to 7-fold vs baseline, P < .001). Under the same condition, the GPER-1 receptor agonist 1-[4-(6-bromo-benzo (1, 3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c] quinolin-8-yl]-ethanone (G-1) (10 nmol/L) mimicked this effect, which was abrogated by cotreatment with either the GPER-1 receptor antagonist (3aS*,4R*,9bR*)-4-(6-Bro-mo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta[c]quinoline (G-15), or a selective protein kinase A inhibitor 8-Bromo-2-monobutyryladenosine-3,5-cyclic mono-phosphorothioate, Rp-isomer. Silencing of the ERβ significantly raised aldosterone synthase expression and aldosterone production. Conversely, silencing of the GPER-1 lowered aldosterone synthase gene and protein expression. Moreover, it blunted the stimulatory effect of E2 on aldosterone synthase that was seen during ERβ blockade. These results support the conclusion that in humans, E2 inhibits aldosterone synthesis by acting via ERβ. Pharmacologic disinhibition of ERβ unmasks a potent secretagogue effect of E2 that involves GPER-1 and protein kinase A signaling.

FULL TEXT can be purchased: HERE

Cardiology, Cardiovascular disease, Estrogen, hormones, hypertension

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Sex Differences and Mitral Valve Surgery
  • Sex Differences in COPD
  • Canadian Journal Requires Sex and Gender Differences in Trials
  • Sex Differences in Zolpidem Clearance and Alcohol Dehydrogenase
  • Busting 5 Common Myths About FDA and Women’s Health

Recent Comments

  • Exec Director on Busting 5 Common Myths About FDA and Women’s Health
  • JR on Busting 5 Common Myths About FDA and Women’s Health
  • JR on Sex specific risks of heart disease and cognition

Receive SGWHC Updates

Would you like to receive our newest articles as soon as they are posted? Just give us your email address in the sign-up box on our Home page.

See our Disclaimer to assure that we won't share your address.

Read Our Newsletter

Read our latest (and archived) Newsletters.

Contact Us

  • 269.207.3426
  • [email protected]
  • Contact Us
    • YouTube
    • Twitter
    • Facebook
    • Linkedin
  • Home
  • Contact Us
  • Blog
  • Medical Meetings
  • Resources
  • Newsletters
  • Disclaimer
(c) 2015 Sex and Gender Womens Health Collaborative
  • Facebook
  • Linkedin
  • Twitter
  • YouTube
  • RSS